Blood sugar and insulin levels also depend on the vagus nerve. As blood sugar levels rise, the vagus nerve stimulates the ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

Key Takeaways, With Data for Maryland FDA approvals vary by drug: There are currently three GLP-1s on the market that the FDA ...

An innovative treatment based on harmine and alpha cells could transform diabetes treatment and reduce insulin dependence ...

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

Shares of Viking Therapeutics (VKTX) are down $2.70, or 6%, to $44.00 in pre-market trading following Merck (MRK) and Chinese biopharmaceutical ...

Evidence is mounting that new therapies already used to treat gut diseases, type 2 diabetes, and obesity may help people with alcohol use disorder (AUD).

Nutraceuticals offer potential health benefits, from migraine relief to cognitive support, but safety and regulatory issues ...

In its latest report, Coresight Research makes six predictions around trends that will transform U.S. retail throughout 2025.